{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:37:49Z","timestamp":1790386669661,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Arthritis, Musculoskeletal and Skin Diseases","award":["65932"],"award-info":[{"award-number":["65932"]}]},{"name":"Center of Excellence Grant in Clinical Translational Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bcmd.2016.12.002","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T02:32:13Z","timestamp":1481596333000},"page":"47-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9223-4637","authenticated-orcid":false,"given":"Vagishwari","family":"Murugesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5206-3028","authenticated-orcid":false,"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiquin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lischuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Pastores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lien","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod K","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2016.12.002_bb0005","first-page":"S6","article-title":"Understanding the natural history of Gaucher disease","volume":"90","author":"Mistry","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2016.12.002_bb0010","first-page":"S12","article-title":"Gaucher disease types 1 and 3: phenotypic characterization of large populations from the ICGG Gaucher registry","volume":"90","author":"Grabowski","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10354-010-0850-x","article-title":"Neuropathic Gaucher disease","volume":"160","author":"Pastores","year":"2010","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminhematol.2004.07.010","article-title":"Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients","volume":"41","author":"Weinreb","year":"2004","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0025","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.12.002_bb0035","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0040","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/2211-5463.12078","article-title":"Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models","volume":"6","author":"Kramer","year":"2016","journal-title":"FEBS Open Bio."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120194","article-title":"Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease","volume":"10","author":"Zigdon","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2016.12.002_bb0050","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","article-title":"Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K","volume":"96","author":"Moran","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.12.002_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012093","article-title":"ADAM10 releases a soluble form of the GPNMB\/osteoactivin extracellular domain with angiogenic properties","volume":"5","author":"Rose","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2016.12.002_bb0060","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1016\/j.febslet.2007.11.036","article-title":"Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3T3 fibroblasts","volume":"581","author":"Furochi","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ijc.2910600111","article-title":"nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts","volume":"60","author":"Weterman","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcmd.2016.12.002_bb0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jcb.1259","article-title":"Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts","volume":"84","author":"Safadi","year":"2001","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jcp.20841","article-title":"Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function","volume":"210","author":"Abdelmagid","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0080","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.yexcr.2008.02.006","article-title":"Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function","volume":"314","author":"Abdelmagid","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0085","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajpath.2013.11.031","article-title":"Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro","volume":"184","author":"Abdelmagid","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0090","doi-asserted-by":"crossref","first-page":"20128","DOI":"10.1074\/jbc.M114.624270","article-title":"Mutation in osteoactivin promotes Receptor Activator of NFkappaB Ligand (RANKL)-mediated osteoclast differentiation and survival but inhibits osteoclast function","volume":"290","author":"Abdelmagid","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0095","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.4049\/jimmunol.178.10.6557","article-title":"Gpnmb is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses","volume":"178","author":"Ripoll","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajh.21362","article-title":"The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients","volume":"84","author":"Taddei","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","author":"Murugesan","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0110","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1073\/pnas.1200941109","article-title":"Gaucher disease gene GBA functions in immune regulation","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"151","key":"10.1016\/j.bcmd.2016.12.002_bb0115","article-title":"Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease","volume":"8","author":"Yildiz","year":"2013","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0120","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.1400768111","article-title":"Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease","volume":"111","author":"Mistry","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1651-2227.2007.00641.x","article-title":"Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease","volume":"97","author":"Aerts","year":"2008","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147208","article-title":"Gpnmb is a potential marker for the visceral pathology in Niemann\u2013Pick type C disease","volume":"11","author":"Marques","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2016.12.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032419","article-title":"Dysregulation of gene expression in a lysosomal storage disease varies between brain regions implicating unexpected mechanisms of neuropathology","volume":"7","author":"Parente","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2016.12.002_bb0140","first-page":"78549","article-title":"Gaucher disease and the synucleinopathies","volume":"2006","author":"Hruska","year":"2006","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0145","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ymgme.2004.06.020","article-title":"Global gene expression in a type 2 Gaucher disease brain","volume":"83","author":"Myerowitz","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0150","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.12.002_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079732","article-title":"Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients","volume":"8","author":"Rolfs","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2016.12.002_bb0160","first-page":"4767","article-title":"The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair","volume":"24","author":"Li","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bcmd.2016.12.002_bb0165","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.2337\/db13-1720","article-title":"Lysosomal stress in obese adipose tissue macrophages contributes to MITF-dependent Gpnmb induction","volume":"63","author":"Gabriel","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.bcmd.2016.12.002_bb0170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gene.2008.01.014","article-title":"Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB","volume":"413","author":"Ripoll","year":"2008","journal-title":"Gene"},{"key":"10.1016\/j.bcmd.2016.12.002_bb0175","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1182\/blood-2006-11-053769","article-title":"DC-HIL is a negative regulator of T lymphocyte activation","volume":"109","author":"Chung","year":"2007","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961630239X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961630239X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:34:56Z","timestamp":1761050096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107997961630239X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":35,"alternative-id":["S107997961630239X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.12.002","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}